We separated the 374 HCC patients into two groups based on the median INKA2-AS1 expression level, a high-expression group (n = 187) and a low-expression group (n = 187), to study further the clinicopathological importance of INKA2-AS1 levels in HCC patients. Here, INKA2 is linked to hepatocellular carcinoma.